Registered Number 05605926
ACUNOVA LIFE SCIENCES LTD
Abbreviated Accounts
31 March 2016
Notes | 2016 | 2015 | |
---|---|---|---|
€ | € | ||
Current assets | |||
Debtors |
|
|
|
Cash at bank and in hand |
|
|
|
|
|
||
Creditors: amounts falling due within one year |
( |
( |
|
Net current assets (liabilities) |
|
|
|
Total assets less current liabilities |
|
|
|
Total net assets (liabilities) |
|
|
|
Capital and reserves | |||
Called up share capital | 2 |
|
|
Profit and loss account |
|
|
|
Shareholders' funds |
|
|
Approved by the Board on
And signed on their behalf by:
1 Accounting Policies
Basis of measurement and preparation of accounts
Turnover policy
Other accounting policies
As the companies day to day trading operations are conducted in Euros, the director is of the opinion that the companies functional currency is Euros and therefore the appropriate reporting currency.
Foreign Currencies
Transactions in Foreign currencies are recorded at the rate ruling at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the rate of exchange at the balance sheet date. All differences are taken the the profit and loss account.
Related Parties
The companies immediate holding company is Manipal Acunova Ltd which owns 100 % of Acunova Life Sciences Ltd issued share capital.
Ecron Acunova GmbH (Advance against invoices) £115,436